AAAAAA
Results: 51-56/56
Authors:
KIRK D
Citation: D. Kirk, MRC STUDY - WHEN TO COMMENCE TREATMENT IN ADVANCED PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 11-15
Authors:
RAJAKOSKI K
PIIRONEN T
PETTERSSON K
LOVGREN J
KARP M
Citation: K. Rajakoski et al., EPITOPE MAPPING OF HUMAN PROSTATE-SPECIFIC ANTIGEN AND GLANDULAR KALLIKREIN EXPRESSED IN INSECT CELLS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 16-20
Authors:
KOIVISTO P
Citation: P. Koivisto, ANEUPLOIDY AND RAPID CELL-PROLIFERATION IN RECURRENT PROSTATE CANCERSWITH ANDROGEN RECEPTOR GENE AMPLIFICATION, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 21-25
Authors:
BYRNES CA
LISS CL
TENOVER JL
LIPPERT MC
GILLENWATER JY
Citation: Ca. Byrnes et al., COMBINED ANALYSIS OF 2 MULTICENTER STUDIES OF FINASTERIDE 5 MG IN THETREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 26-31
Authors:
ARAKAWA A
SOH S
CHAKRABORTY S
SCARDINO PT
WHEELER TM
Citation: A. Arakawa et al., PROGNOSTIC-SIGNIFICANCE OF ANGIOGENESIS IN CLINICALLY LOCALIZED PROSTATE-CANCER (STAINING FOR FACTOR VIII-RELATED ANTIGEN AND CD34 ANTIGEN), PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 32-38
Authors:
YU EY
YU E
MEYER GE
BRAWER MK
Citation: Ey. Yu et al., THE RELATION OF P53 PROTEIN NUCLEAR ACCUMULATION AND ANGIOGENESIS IN HUMAN PROSTATIC-CARCINOMA, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 39-44